We are live on
!
Find out more
HWAM
Hennion & Walsh Asset Management Portfolio holdings
AUM
$3.5B
1-Year Est. Return
41.95%
This Fund
S&P 500
This Quarter
Est. Return
-6.9%
1 Year Est. Return
+41.95%
3 Year Est. Return
+93.92%
5 Year Est. Return
+100.55%
10 Year Est. Return
–
AUM
$1.88B
AUM Growth
-$154M
(-7.6%)
Cap. Flow
+$19.9M
Cap. Flow
% of AUM
1.06%
Top 10 Holdings %
Top 10 Hldgs %
16.6%
Holding
823
New
81
Increased
382
Reduced
295
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$17.4M |
| 2 |
Vanguard S&P Small-Cap 600 ETF
VIOO
|
+$9.8M |
| 3 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$8.74M |
| 4 |
State Street Blackstone Senior Loan ETF
SRLN
|
+$3.91M |
| 5 |
Goldman Sachs ActiveBeta US Large Cap Equity ETF
GSLC
|
+$3.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WisdomTree Emerging Markets ex-State-Owned Enterprises Fund
XSOE
|
+$13.6M |
| 2 |
iShares MSCI Emerging Markets ex China ETF
EMXC
|
+$9.25M |
| 3 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$4.19M |
| 4 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$4.08M |
| 5 |
Amazon
AMZN
|
+$3.49M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.25% |
| 2 | Technology | 10.56% |
| 3 | Financials | 10.37% |
| 4 | Industrials | 5.46% |
| 5 | Consumer Discretionary | 4.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Coherus Oncology
CHRS
$187M
| $1.89M | 0.1% |
146,089
-5,258
| -3% | -$66.9K |
|
227
Southern Company
SO
$106B
| $1.87M | 0.1% |
25,729
+1,497
| +6% | +$101K |
|
228
iShares International Select Dividend ETF
IDV
$8.52B
| $1.85M | 0.1% |
58,321
-5,371
| -8% | -$172K |
|
229
Citizens Financial Group
CFG
$30.7B
| $1.85M | 0.1% |
40,799
-25,740
| -39% | -$1.32M |
|
|
BBBY
230
Bed Bath & Beyond
BBBY
$407M
| $1.83M | 0.1% |
45,723
+17,636
| +63% | +$784K |
|
231
Teradyne
TER
$59.3B
| $1.82M | 0.1% |
15,435
+375
| +2% | +$47.5K |
|
|
RVNC
232
DELISTED
Revance Therapeutics, Inc.
RVNC
| $1.82M | 0.1% |
93,156
-3,353
| -3% | -$50.9K |
|
|
BSCO
233
DELISTED
Invesco BulletShares 2024 Corporate Bond ETF
BSCO
| $1.81M | 0.1% |
85,924
-3,198
| -4% | -$68.5K |
|
234
Equinix
EQIX
$102B
| $1.8M | 0.1% |
2,423
-951
| -28% | -$684K |
|
235
TTEC Holdings
TTEC
$84.2M
| $1.8M | 0.1% |
21,782
-78
| -0.4% | -$6.26K |
|
236
3M
MMM
$94.4B
| $1.8M | 0.1% |
14,425
+856
| +6% | +$114K |
|
|
BSCP
237
DELISTED
Invesco BulletShares 2025 Corporate Bond ETF
BSCP
| $1.79M | 0.1% |
85,452
-2,589
| -3% | -$55.3K |
|
238
Global X NASDAQ-100 Covered Call ETF
QYLD
$8.27B
| $1.78M | 0.09% |
85,102
-5,407
| -6% | -$112K |
|
239
Nektar Therapeutics
NKTR
$2.55B
| $1.77M | 0.09% |
21,954
+1,312
| +6% | +$194K |
|
|
ICPT
240
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $1.77M | 0.09% |
108,984
-4,264
| -4% | -$66.8K |
|
241
Global X SuperIncome Preferred ETF
SPFF
$142M
| $1.77M | 0.09% |
158,444
-12,040
| -7% | -$135K |
|
|
ATVI
242
DELISTED
Activision Blizzard
ATVI
| $1.73M | 0.09% |
21,537
-8,707
| -29% | -$678K |
|
243
Williams Companies
WMB
$88.4B
| $1.72M | 0.09% |
51,465
+1,590
| +3% | +$48.6K |
|
244
VanEck Emerging Markets High Yield Bond ETF
HYEM
$527M
| $1.71M | 0.09% |
84,544
-458
| -0.5% | -$9.58K |
|
|
AIF
245
DELISTED
Apollo Tactical Income Fund Inc.
AIF
| $1.7M | 0.09% |
118,394
+47,868
| +68% | +$712K |
|
|
CCXI
246
DELISTED
ChemoCentryx, Inc.
CCXI
| $1.7M | 0.09% |
67,790
+11,447
| +20% | +$322K |
|
247
Arcutis Biotherapeutics
ARQT
$3.3B
| $1.68M | 0.09% |
87,369
+22,021
| +34% | +$373K |
|
248
Exelixis
EXEL
$12.7B
| $1.64M | 0.09% |
72,473
-3,646
| -5% | -$71.2K |
|
249
Heron Therapeutics
HRTX
$61.3M
| $1.62M | 0.09% |
283,954
-12,098
| -4% | -$88.5K |
|
250
SLR Investment Corp
SLRC
$706M
| $1.62M | 0.09% |
89,437
+34,727
| +63% | +$635K |
|
Similar funds
TCM
BCP
DILIC
TYCC
ACM
MSC
DAM
PCM
Hennion & Walsh Asset Management's Q1 2022 Portfolio in Review
As of Q1 2022, Hennion & Walsh Asset Management held 823 positions worth $1.88B, down 7.6% from $2.04B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Hennion & Walsh Asset Management's Q1 2022 filing shows 81 new, 382 increased, 295 reduced and 54 closed positions. Its largest new stake was Vanguard S&P Small-Cap 600 ETF: 99,010 shares worth $9.8M. The largest sale was WisdomTree Emerging Markets ex-State-Owned Enterprises Fund, an estimated $13.6M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
- Hennion & Walsh Asset Management's largest Q1 2022 buy was Vanguard S&P Small-Cap 600 ETF: 99,010 shares worth $9.8M.
- Hennion & Walsh Asset Management added most to iShares Core MSCI Emerging Markets ETF in Q1 2022, an estimated $17.4M increase.
- Hennion & Walsh Asset Management's biggest Q1 2022 reduction was Amazon, cutting an estimated $3.49M.
- Hennion & Walsh Asset Management fully exited WisdomTree Emerging Markets ex-State-Owned Enterprises Fund in Q1 2022, selling an estimated $13.6M.
- Hennion & Walsh Asset Management's ten largest holdings make up 17% of its $1.88B portfolio in Q1 2022.
- Hennion & Walsh Asset Management opened 81 new positions and closed 54 in Q1 2022.
- Hennion & Walsh Asset Management's portfolio value fell 7.6% quarter-over-quarter to $1.88B.
Based on Hennion & Walsh Asset Management's 13F filing for Q1 2022, filed 26 Apr 2022.